Pot Luck: Marketing cannabis-based products for medicinal use in the UK
27 February 2019
Following several high-profile cases advocating the medicinal benefits of cannabis, in late 2018 the UK government implemented changes to the classification scheduling of cannabis-based products for medicinal use ("CBPMs"). Consequently, it is now possible for businesses to manufacture, import, supply and distribute CBPMs in the UK under certain medical product regulatory regimes.
Download PDF